HOME >> BIOLOGY >> NEWS
Vertex Pharmaceuticals/Yale Research Team Uses Gene Knockout Mice To Establish Role Of Caspase-9 In Neuronal Cell Death Pathway

-9 function through a gene-knockout experiment, and illustrates how Vertex approaches functional genomics as part of an integrated discovery platform," said Dr. Joshua Boger, Chairman, President, and CEO of Vertex. "This research clarifying the relationship between caspases and their activity in body tissues greatly increases our understanding of which caspases are appropriate targets for drug discovery."

Vertex Pharmaceuticals has an established track record of scientific innovation and is a leader in caspase research. Previously, Vertex and Yale/HHMI researchers were the first to describe the biochemical and physiological effects of the ICE (Caspase-1) enzyme through a gene knockout mouse experiment, and Vertex researchers were the first to elucidate the 3-dimensional atomic structure of ICE. Additionally, Dr. Keisuke Kuida, together with colleagues Dr. Richard Flavell and Dr. Pasko Rakic, reported the first Caspase-3 (CPP32) gene knockout mouse, and Vertex researchers have solved the structure of the Caspase-3 enzyme. Vertex and partner Hoechst Marion Roussel plan to begin Phase I clinical trials of VX-740, an inhibitor of ICE targeting inflammatory diseases, later in 1998. Vertex has a research program directed at developing novel, orally administered inhibitors of different targets in the caspase family with potential in the treatment of stroke, Alzheimer's and Parkinson's diseases, myocardial ischemia and other indications.

The contributors to the Cell paper include Dr. Richard Flavell, a Howard Hughes Investigator, and Drs. Pasko Rakic, Tarik Haydar, and Chia-Yi Kuan, all of the Yale University School of Medicine; Drs. Choji Taya and Hajime Karasuyama, both of the Tokyo Metropolitan Institute of Medical Science; and Drs. Keisuke Kuida, Yong Gu and Michael Su, all of Vertex.

Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) is engaged in the discovery, development and commercialization of novel, small molecule pharmaceuticals for the treatme
'"/>

Contact: Michael Partridge
partridge@vpharm.com
(617) 577-6108
Vertex Pharmaceuticals
7-Aug-1998


Page: 1 2 3 4

Related biology news :

1. Research Findings Suggest Potent, Broad-Spectrum Antiviral Activity For Vertexs Investigational IMPDH Inhibitor VX-497
2. Phase III Results Suggest Potent Antiviral Activity For Vertex And Glaxo Wellcomes Second-Generation HIV Protease Inhibitor Agenerase TM
3. Vertex Researchers Report Three-Dimensional Atomic Structure Of JNK3 Enzyme; Report In Structure
4. Vertex Pharmaceuticals Researchers Report Three-Dimensional Structure Of Hepatitis C Helicase Enzyme; Report In Structure
5. Researchers determine genetic cause of Timothy syndrome
6. Researchers find color sensitive atomic switch in bacteria
7. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
8. Researchers identify protein promoting vascular tumor growth
9. Researchers devise potent new tools to curb ivory poaching
10. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
11. Researchers ID chlorophyll-regulating gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... ... 2018 , ... Superior Controls, Inc. , a leading ... employees on both the east and west coasts, today announced the company has ... control system integrators must pass an intensive audit every three years to demonstrate ...
(Date:11/15/2018)... (PRWEB) , ... November 15, 2018 , ... Firmex today ... Firmex and Divestopedia surveyed over 480 investment bankers and M&A advisors worldwide to compile ... share their insights on the key findings in the report. , Highlights in ...
(Date:11/15/2018)... ... November 14, 2018 , ... Persivia, ... solutions, announced today that Prime Healthcare, a leading operator of over 50 hospitals ... , Persivia’s Bundled Payment solution consists of the industry’s only end to ...
Breaking Biology News(10 mins):
(Date:11/15/2018)... ... 14, 2018 , ... Hüpnos announces the launch ... public. It is estimated that 90 million Americans suffer from persistent ... The resulting daytime fatigue causes extreme difficulty with concentration, focus and memory. ...
(Date:11/13/2018)... ... , ... Renowned Honolulu veterinarian, Dr. Patrick Leadbeater, has begun offering VetStem ... of Kahala Pet Hospital on Oahu, is a skilled surgeon who has ... island of Kauai on an almost weekly basis to perform surgery at Kapaa ...
(Date:11/13/2018)... , ... November 12, 2018 , ... ... reduce stethoscope contamination that two large U.S. studies, published last week, confirm pose ... American Journal of Infection Control (AJIC) conclude that stethoscopes are often improperly or ...
(Date:11/13/2018)... ... November 12, 2018 , ... Dr. Dan Myers, ... Sandy Springs, now welcomes new patients for MTM® Clear Aligners. Offering a variety ... traditional braces in the Sandy Springs and Alpharetta areas. Constantly on the forefront ...
Breaking Biology Technology:
Cached News: